Common BUDs for compounded tirzepatide are 28, 45, or 56 days from compounding
The service is designed to combine medical oversight with structured weight management support, helping people access evidence-based treatment responsibly
When adverse effects occur, they are typically mild and may include: Nausea or stomach upset Diarrhea or loose stools (particularly at higher doses) Dizziness Headache Fatigue These effects are usually dose-dependent and resolve with dosage adjustment
Eli Lilly's prescribing information does not list alcohol as a contraindication or known drug interaction for tirzepatide
Patients with heart disease, high blood pressure, or cardiovascular risk factors Patients with liver disease or abnormal liver enzymes Patients with hormone-sensitive conditions Patients with fertility concerns or active family-planning goals Patients with a history of mood disorders, aggression, anxiety, or depression Patients taking medications that may interact with hormone or metabolic pathways Competitive athletes subject to drug testing rules Anyone considering products labeled research use only or sold without medical oversight A medical consultation can help determine whether peptide therapy, hormone testing, lifestyle changes, recovery support, or another treatment is the safer fit
Add the needle to your syringe, careful not to touch the needle with your fingers